Drugs industry protecting 'morally unacceptable' patent system

Major drugs companies are using fierce lobbying tactics to protect a pharmaceutical patent system that is "simply morally unacceptable", a world-leading political philosopher will tell a major meeting of UK and European pharmacologists today.